The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.

CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the most shorted mid-cap and small-cap stocks to buy now. On May 27, research firm Citizens reiterated a Market Perform rating and a $60 price target on CRISPR Therapeutics AG (NASDAQ:CRSP).

The stance comes on the heels of the company maintaining a positive view of in vivo editing in cardiovascular disease. Its clinical data, presented at the European Atherosclerosis Society Congress, continues to draw strong interest in gene-editing approaches. That’s because they offer new modalities that can deliver profound and sustained lipid-lowering effects.

The company continues to advance its diversified portfolio of in vivo gene-editing programs, leveraging its proprietary liver-directed LNP delivery platform. For starters, CTX310®, a therapy targeting angiopoietin-like protein 3 (ANGPTL3), is progressing in a Phase 1b clinical trial for severe hypertriglyceridemia (sHTG) and refractory hypercholesterolemia.

CRISPR Therapeutics is also working on CTX460, for the treatment of alpha-1 antitrypsin deficiency (AATD), and CTX340, which targets angiotensinogen (AGT) for refractory hypertension.

CRISPR Therapeutics AG (NASDAQ:CRSP) develops transformative gene-based medicines using CRISPR/Cas9 gene-editing technology. Its core focus is modifying specific genes to correct the underlying causes of serious human diseases, including genetic disorders, cancers, and autoimmune conditions.

While we acknowledge the potential of CRSP as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: Top 10 Small Cap Stocks With Huge Growth Potential and Renaissance Technologies Returns, AUM, CEO and Top 10 Semiconductor Stock Picks.

Disclosure: None. Follow Insider Monkey on Google News.